TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

American Renal Associates Holdings, Inc. (NYSE: ARA) Investor Securities Class Action Lawsuit 03/28/2019

  • You must submit the settlement "Proof" form attached below, in order to participate in this settlement. There is a strict deadline of January 4, 2021 by which all claims must be submitted. The instructions for submitting are included in the "Proof" and the "Notice" files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Company
American Renal Associates Holdings Inc
Security
NYSE: ARA

Case Name
American Renal Associates Holdings Shareholder Class Action Lawsuit 03/28/2019
Type of Lawsuit
Shareholder Class Action
Court of Filing
U.S. District Court for the District of New Jersey

Class Period Begin
Class Period End
Deadline To File for Lead
Settlement Notice
American_Renal_Settlement_01_04_2020.pdf
Settlement Proof
American_Renal_Proof_01_04_2020.pdf
You must register or login to receive notifications.

Click here to subscribe to American Renal Associates Holdings Inc.

Settlement Overview

Date Settled
Date Settled
Settlement Amount
$5,775,000.00
Deadline to Participate in Settlement

You must register to view and download the Settlement Notice and Settlement Proof.

Summary

September 3, 2020 - The court preliminarily approved the settlement.

June 25, 2020 - A stipulation and agreement of settlement was entered by the parties.

November 11, 2019 - A consolidated amended complaint was filed.

March 28, 2019 - An investor in shares of American Renal Associates Holdings, Inc. (NYSE: ARA) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by American Renal Associates Holdings, Inc. in connection with certain allegedly false and misleading statements made between August 10, 2016 and March 27, 2019.

According to the complaint the plaintiff alleges on behalf of purchasers of American Renal Associates Holdings, Inc. (NYSE: ARA) common shares between August 10, 2016 and March 27, 2019, that the defendants violated Federal Securities Laws. Beverly, MA based American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. American Renal Associates Holdings, Inc. reported that its annual Total Revenue declined from $749.76 million in 2016 to $745.1 million in 2017 and that its Net Loss of $0.385 million in 2016 turned into a Net Income of $4.85 million in 2017. Shares of American Renal Associates Holdings, Inc. (NYSE: ARA) reached $23.49 per share on October 1, 2018.

On March 8, 2019, American Renal Associates Holdings, Inc. announced it would delay the filing of its earnings report for the fiscal year ended December 31, 2018 as it continues to examine reserve computations and other accounting practices that may have an impact on the company’s accounts receivable and revenue for fiscal year 2018, as well as previously reported fiscal years ranging from 2014 through 2017.

Shares of American Renal Associates Holdings, Inc. (NYSE: ARA) declined to $9.20 per share on March 11, 2019.

Date Settled